Celldex at SNO 2015 in San Antonio

There’s always something new happening at Celldex! Come check out our latest activities.

ReACT Presentation at SNO 2015

Dr. Reardon Discusses the ReACT Study
Dr. David Reardon (Dana-Farber Cancer Institute, Harvard Medical School), lead investigator of the ReACT study, discussed the results of the study at the 2015 Annual Scientific Meeting of the Society for Neuro-Oncology (SNO).


About us

Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response.


Our Pipeline